Lineage Cell Therapeutics, Inc. - Common shares (LCTX)

Historical Holders from Q2 2019 to Q3 2025

Symbol
LCTX on NYSE
Type / Class
Equity / Common shares
Shares outstanding
250,425,788
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
87,923,479
Holdings value
$148,571,752
% of all portfolios
0%
Number of holders
111
Number of buys
40
Number of sells
-66
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Lineage Cell Therapeutics, Inc. - Common shares (LCTX)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BROADWOOD PARTNERS, L.P. 23.1% -5.6% $97,763,723 57,848,357 0% NEAL C. BRADSHER 12 Nov 2025
Chernett Jorey 5% $13,848,454 11,445,003 Chernett Jorey 22 Sep 2025
BlackRock, Inc. 1% -80% $2,027,626 -$8,365,103 2,234,545 -80% BlackRock, Inc. 30 Jun 2025

Institutional Holders of Lineage Cell Therapeutics, Inc. - Common shares (LCTX)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 87,923,479 $148,571,752 -$9,352,343 $1.69 111
2025 Q2 97,785,816 $88,366,897 -$8,826,258 $0.9074 128
2025 Q1 109,349,495 $49,687,946 +$369,638 $0.4516 126
2024 Q4 107,111,044 $53,827,848 +$3,921,589 $0.5025 119
2024 Q3 94,568,251 $85,611,699 -$260,148 $0.9053 112
2024 Q2 94,431,242 $94,175,668 +$447,460 $0.9973 110
2024 Q1 93,427,423 $138,270,047 +$26,536,201 $1.48 113
2023 Q4 75,708,353 $82,523,932 +$188,614 $1.09 114
2023 Q3 75,504,077 $89,104,877 -$402,119 $1.18 102
2023 Q2 75,637,865 $106,648,039 +$8,457,693 $1.41 105
2023 Q1 69,793,059 $104,687,354 +$7,197,215 $1.5 114
2022 Q4 65,070,787 $76,138,155 +$591,571 $1.17 99
2022 Q3 64,712,443 $73,129,667 -$348,315 $1.13 88
2022 Q2 64,980,785 $102,682,821 -$12,116,491 $1.58 84
2022 Q1 72,831,378 $112,314,619 -$3,915,128 $1.54 99
2021 Q4 73,975,180 $181,237,026 -$5,349,258 $2.45 110
2021 Q3 75,827,690 $191,741,083 +$6,640,880 $2.52 106
2021 Q2 73,147,470 $208,518,897 +$38,013,987 $2.85 103
2021 Q1 60,314,515 $141,778,049 +$12,436,479 $2.35 90
2020 Q4 55,072,841 $96,924,151 +$3,142,777 $1.76 78
2020 Q3 53,561,495 $50,165,088 -$1,850,541 $0.9366 65
2020 Q2 55,701,303 $48,461,276 -$6,974,131 $0.8697 80
2020 Q1 63,835,650 $52,851,654 +$405,531 $0.8278 81
2019 Q4 63,343,880 $56,369,746 -$1,146,000 $0.8901 86
2019 Q3 64,455,811 $63,153,426 +$63,033,394 $0.9799 81
2019 Q2 17,974 $20,000 +$20,000 $1.11 1